Unlock Exclusive Insider Products
Join now and receive discounts on your next purchase.
Pickup currently not available
NOT FOR HUMAN CONSUMPTION
BPC-157 (Body Protection Compound-157) is a peptide composed of 15 amino acids, derived from a protein found in the human stomach. It has gained popularity in the wellness, bodybuilding, and healing communities for its potential to speed up the recovery process from injuries, improve tissue repair, and protect organs.
BPC-157 is not FDA-approved for clinical use, and most of the information regarding its efficacy comes from animal studies and anecdotal evidence from users. It is typically administered through subcutaneous injections, although there are other delivery methods (oral or topical).
BPC-157 works by promoting various biological processes in the body that aid in tissue repair, inflammation reduction, and overall healing. Some of its main mechanisms include:
Injury Healing & Tissue Regeneration:
Joint Health:
Gut Health:
Reduction of Inflammation:
Neuroprotection and Brain Health:
Enhanced Recovery for Athletes:
BPC-157 is commonly administered via subcutaneous injections, although some users opt for oral tablets or topical applications (though these forms are considered less effective).
Injection: This is the most effective method to ensure BPC-157 is absorbed directly into the bloodstream, bypassing the digestive system. It’s typically injected near the injury site for localized healing benefits.
Oral and Topical: Some peptides may be taken orally or applied topically. However, this route may have reduced bioavailability compared to direct injection.
While BPC-157 is generally considered safe, there are potential side effects and risks to be aware of, especially given that its clinical use in humans has not been widely studied. Some of the reported side effects include:
References
Sikiric, P., et al. (2011). Stable Gastric Pentadecapeptide BPC 157: Novel Therapy for Wound Healing, Tissue Regeneration and Protection. Current Pharmaceutical Design, 17(36), 4062–4069.
Sikiric, P., et al. (2007). BPC 157 and the Cytoprotection/Repair Paradigm: A New Approach to Therapy. Journal of Physiology and Pharmacology, 58(Suppl 6), 9–31.
Seiwerth, S., et al. (2006). Angiogenic Potential of BPC 157: A Novel Approach for Improving Wound Healing.Angiogenesis, 9(3), 203–210.
Sikiric, P., et al. (2018). BPC 157 and the Gut–Brain Axis: New Implications for Neuroprotection and Neural Repair.Frontiers in Pharmacology, 9, Article 695. [DOI: 10.3389/fphar.2018.00695]
Brcic, L., et al. (2017). The Healing Properties of BPC 157: A Comprehensive Review. Journal of Physiology and Pharmacology, 68(3), 283–298.